Want to mitigate development-risks of your translational project? Improve your grant- application success? Or explain your family and friends in a simple way, what you are actually working on?
In this SPARK Europe Webinar, Dr. Liliane Brunner Halbach, will explain how evaluating the unmet clinical need early on in the development process will help you minimize the risks associated with the development of your new technology. She will introduce us to the process of assessing the unmet need and how the gained knowledge is the basis of designing the Target Product Profile. Clinical need assessment helps to direct your project development plans towards defining your ideal end product early on and focus your work towards solving a real life problem.
Dr. Liliane Brunner Halbach is a senior Healthcare professional with global experience in Drug Research, Development, Marketing, Business Strategy, Supply Chain and Translational Research at Novartis, Roche and AstraZeneca. She is using data to identify opportunities & support decision making. Over the past years she has been a mentor for start-ups and a consultant for biotech and pharma companies to support them in their clinical development strategy and assessing companies to acquire.
Online via Zoom – Please register here!
The webinar is open to all interested people from SPARK associated organizations. Registration to the webinar is required.
SPARK EUROPE WEBINAR SERIES
The SPARK Europe webinar series is organized by the different SPARK sites from all over Europe including Israel: SPARK-BIH, SPARK Finland, SPARK FLI in Jena, SPARK Poland and SPARK Tel Aviv. The series takes advantage of the collective expertise and experiences from top-quality speakers and covers topics from value proposition and pitching to the do's and don'ts in biopharma business. The online webinar series takes place twice per month on Wednesday at 16:00 - 17:00 CET.
